Opendata, web and dolomites

OCTAV SIGNED

A novel approach to non-invasive and personalized skin cancer diagnosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OCTAV project word cloud

Explore the words cloud of the OCTAV project. It provides you a very rough idea of what is the project "OCTAV" about.

platform    first    imaging    skin    financial    initially    covered    disruptive    validation    interpretation    public    french    storage    handling    cancers    aided    ing    assist    regulatory    cellular    adoption    industrialization    recurrence    paradigm    cancer    worldwide    coherence    risk    conjunction    2017    image    resolution    scars    medical    preventing    designed    burden    segment    accurate    layers    optical    healthcare    phase2    deploying    patient    practices    services    clinicians    earlier    scaleup    company    clinical    software    device    benign    private    capture    telepathology    solution    lesions    margins    confocal    computer    oct    trl9    routine    correlatively    releasing    trl6    sme    dermatologists    melanoma    biopsies    successfully    octav    approval    atlas    lc    market    surgery    invasive    instrument    feasibility    tomography    issue    data    guide    presurgical    damae    fewer    changing    dermatological    performant    consisting    diagnostic    definitive    prototype    line    unnecessarily    reducing    situ    consolidated    dermoscopy    images    full    larger    cloud    detection    diagnosis   

Project "OCTAV" data sheet

The following table provides information about the project.

Coordinator
DAMAE MEDICAL 

Organization address
address: BATIMENT 503 - CAMPUS SCIENTIFIQUE D'ORSAY
city: ORSAY
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙485˙857 €
 EC max contribution 2˙400˙000 € (69%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DAMAE MEDICAL FR (ORSAY) coordinator 2˙400˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

French SME-company DAMAE Medical is facing skin cancer worldwide issue by developing the OCTAV Project, a new approach to dermatological diagnostic based on a disruptive Line-field Confocal Optical Coherence Tomography (LC-OCT) technology, in a novel hand-held imaging device. OCTAV is designed to capture in situ images of the skin layers with a cellular resolution. It is used in conjunction with dermoscopy to provide more accurate diagnosis, leading to fewer biopsies of benign lesions and earlier detection of melanoma (clinical use 1) and non-melanoma skin cancers (clinical use 2). It may also guide the surgery to provide more accurate presurgical margins (clinical use 3), preventing unnecessarily large scars and reducing the risk of recurrence. Correlatively, DAMAE is developing a full software solution, based on a data storage cloud-platform, a computer-aided software designed to assist dermatologists with OCTAV image interpretation, as well as telepathology and patient services. OCTAV device will initially be used by clinicians as a routine easy-handling diagnostic device in public practices (market segment 1). Implementation of OCTAV software will enable its adoption by a much larger market, consisting of private practices dermatologists (market segment 2). The approach will contribute to the development of skin cancer risk patient awareness, while changing the current paradigm through a timely, performant, and non-invasive approach, and releasing the financial burden on the healthcare system. Project OCTAV has successfully completed in 2017 a feasibility phase covered by the SME Instrument Phase 1, resulting in a TRL6 prototype of the technology and a first consolidated atlas of skin cancer clinical images. The main objective of this Phase2 is to scaleup the OCTAV solution to TRL9 through industrialization activities and by achieving a definitive market assessment, the clinical validation and the regulatory approval, before deploying the approach worldwide.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCTAV" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OCTAV" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More  

STURSKIN (2018)

Innovative products by using tanned sturgeon skin

Read More